we determine which factors most significantly change the power/MSSN for all statistics. Finally, we determine which test statistics have the smallest MSSN. In this work, MSSN calculations are for 2 traits (bivariate distributions) only (for illustrative purposes). We note that the calculations may be extended to address any number of traits. Our key findings are that the genotype test usually has lower MSSN requirements than the LTT. More inclusive thresholds (top/bottom 25% vs. top/bottom 10%) have higher sample size requirements. The Pillai test has a much larger MSSN than both the genotype test and the LTT, as a result of sample selection. With these formulas, researchers can specify how many subjects they must collect to localize genes for pleiotropic phenotypes.
otropy refers to the phenomenon in which a single locus affects two or more apparently unrelated phenotypic traits and is often identified as a single mutation that affects two or more wild-type traits." [1] We translate this definition into a mathematical model in the Methods section.
As of this writing, searching the term "pleiotropy" under "Topic" in the ISI Web of Science database yields over 11,000 publications. This number suggests that pleiotropy is both a common phenomenon and one that has been well studied. A significant number of these publications (over 1,300 according to ISI Web of Science) deal with mice, flies, plants, dogs, chickens, and other animals/organisms. There are a host of statistically powerful techniques available for gene mapping in these model organisms [see, e.g., 2 for mice].
In humans, there are numerous examples of pleiotropic effects that are correlated with traits and/or diseases. Some examples include colorectal cancer [3, 4] , Crohn disease [3, [5] [6] [7] [8] [9] [10] , Alzheimer disease [11] [12] [13] [14] [15] [16] [17] [18] [19] , and Marfan syndrome [20] [21] [22] . Papers by Baumgartner et al. [22] and Solovieff et al. [23] highlight some challenges regarding the study of pleiotropic traits in humans. One challenge is the computation of the statistical power and/or the minimum sample size necessary (MSSN) for genetic association, a critically important component of any gene mapping work. With these values, researchers may obtain a realistic estimate either of the MSSN to establish genetic associations or of the probability of detecting genetic associations for a collected sample. Power and MSSN calculations for single-phenotype tests of genetic association have been derived by Mitra [24] for the χ 2 test of independence on alleles/genotypes and by several authors [25] [26] [27] [28] for the linear trend test (LTT). From this point forward, we refer to the former and the latter test as the "genotype test" (since the data collected are genotypes on individuals) and the "LTT," respectively.
There have been a number of publications documenting ways to detect and analyze pleiotropic data, most recently for genome-wide association studies [23, , and also reporting methods to determine power and/or MSSN for association mapping [43, 45, 46, [59] [60] [61] [62] [63] [64] [65] [66] . If one broadens the search to allow for multiple phenotypes that may not be pleiotropic, the list of published methods increases [34, [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] . Studying these methods, we noted that the majority deal with data analysis. We comment that a number of authors who document the power for their method do so by simulation [e.g., 45 , 47 ] or for a specific data set [e.g., 6 , 60 , 86 ] .
The purpose of this work was the development of an analytic approach to computing (1) the statistical power for a fixed sample size and a given significance level or (2) the MSSN (in terms of affected and unaffected individuals) to achieve a fixed power at a given significance level for a number of different statistical tests. Our method is threshold based, in the sense that we transform individuals with quantitative phenotype vector values into either affected or unaffected individuals using thresholds. From this point forward, we will use the abbreviations QT for "quantitative trait"/"quantitative phenotype" and QTV for "quantitative trait value" to refer to an individual's quantitative phenotype vector values.
Our method is a natural extension of the univariate threshold-selected QT association power and the MSSN calculator [e.g., 87 , 88 ] , in that when the number of phenotypes is 1, our method is reduced to the univariate method. Some suggested benefits of our method are that (a) it is based on classic quantitative genetic mapping methods for selected sampling and (b) the mathematics used is well established and straightforward to implement.
We use a threshold approach because a number of pleiotropic diseases are defined this way. For example, Marfan syndrome and Tourette syndrome are composed of multiple traits, each of which may be caused by a single gene on the chromosome [2] . The phenotypes caused by these disorders are also quantitative or continuously distributed. That is, individuals may exhibit these traits to varying degrees (e.g., mild to severe). We note that each trait may be defined by thresholds for different QTs. Thresholds are provided below.
For the syndromes listed below, each of the conditions listed is necessary.
(1) Marfan syndrome: according to the Marfan Foundation [89] , one definition of Marfan syndrome in the absence of a family history [90] encompasses (a) an aortic root dilatation Z score ≥ 2 and (b) a systemic score ≥ 7 points.
(2) For a person to be diagnosed with Tourette syndrome [91] , he or she must (a) have ≥ 2 motor tics (e.g., blinking or shrugging shoulders), (b) have ≥ 1 vocal tic (e.g., humming, clearing the throat, or yelling out words or phrases), although they might not always happen at the same time, (c) have had tics (a) and (b) for ≥ 1 year (the tics can occur many times a day [usually in bouts] nearly every day, or on and off), (d) have tics that had started at ≤ 18 years of age, and (e) have symptoms that are not due to taking medicine or other drugs or due to having another medical condition (e.g., seizures, Huntington disease, or postviral encephalitis).
Additionally, we make a distinction between pleiotropy and locus heterogeneity. In Tourette syndrome, there is documented evidence of locus heterogeneity [92, 93] . Hence, in a particular family, it may be that these traits are "caused by a single gene" with a high penetrance. However, this situation is not what we mean by pleiotropy. For pleiotropy, it must be the same gene causing changes in multiple phenotypes across families/individuals.
We include a section on derivation of the power/ MSSN for multivariate ANOVA (MANOVA) using the Pillai trace statistic applied to the quantitative measures directly. Our reasons are the following: (1) several published methods consider the power and/or MSSN for pleiotropic phenotypes using quantitative measures [31, 32, 36, 40, 42, 45, [94] [95] [96] [97] [98] [99] [100] [101] ; (2) while there is no uniformly most powerful test for MANOVA using equality of means as the null hypothesis, the Pillai trace statistic has high power in a number of different settings; and (3) the Pillai trace statistic is robust to several violations of assumptions in the MANOVA model [102, 103] . We perform a comparison of the MSSN for the Pillai statistic and our statistics using specified genetic model parameter settings.
Finally, we develop software that performs power and/ or MSSN calculations for detecting genetic associations with (1) the LTT and the genotype test for thresholddefined phenotypes and (2) Pillai's trace statistic for the original phenotypes. We note that this software is an extension of software programs designed to compute power and/or MSSNs considering a single locus and a single phenotype. In this work, MSSN calculations are for 2 traits (bivariate distributions) only. Our calculations may be extended to address any number of traits.
Methods 1
Test Statistic for One-Way MANOVA Here, we present the test statistic used to test our multiple null hypotheses when the data are quantitative. Several multivariate mean vectors in a one-way MANOVA may be statistically compared using Wilks's lambda, Pillai's trace, Roy's largest root, or Hotelling-Lawley's tests [102, 103] . Though none of the tests is uniformly most powerful, Pillai's trace statistic is reported to have good power in many scenarios and is robust to deviations from assumptions specified in MANOVA [102] . As an indication of its popularity, Pillai's trace test is the default test in the manova function of the R statistical software package [106] . Wilks's lambda is equivalent to the likelihood ratio test, and it has similar power to Pillai's statistic in many alternative settings [102, 103] .
Notation for the Pillai Statistic
Here, we define the null hypotheses for the Pillai statistic and the statistic itself:
g : Number of groups considered for each phenotype; here, g is the number of genotypes at a SNP locus, so that g = 3;
p : Number of phenotypes (response variables).
Definition of the Pillai Statistic
Here, we present the Pillai trace statistic. It is used to test our multiple null hypotheses when the data are quantitative. As an indication of its popularity, Pillai's trace test is the default test in the manova function of the R statistical software package [106] . Wilks's lambda is equivalent to the likelihood ratio test and has similar power to Pillai's statistic in many alternative settings [102, 103] .
To begin, let is an n i × p data matrix, and y ijk is the j -th observation of the i -th phenotype in the k -th genotype group, the total number of observations being denoted by N = n 1 + … + n g . Note that 1 ≤ i ≤ g , 1 ≤ j ≤ n i for the i -th genotype group, and 1 ≤ k ≤ p . Also, n i is the number of individuals with the i -th genotype. Let X denote the N × g design matrix given by 
Note that the matrix B  is the matrix B with parameters estimated from the data. The matrices C and A are stated below. The estimate of each μ ij is given by 1 1 .
The Pillai statistic has an F distribution with df 1 = r C r A and df 2 = s ( N -r X + s -r A ) degrees of freedom under the null hypothesis. Note that r C , r A , and r X are the ranks of the matrices C , A , and X , respectively.
Null Hypothesis
We can write a linear hypothesis in a one-way MANOVA as and φ * i is the i -th largest eigenvalue of
where p j = n j / N or the limit of the ratio as N → ∞ . We specify that the phenotype vectors in all groups have the common covariance matrix Σ . This common covariance matrix specification is necessary to derive the NCP. Note that for threshold-based phenotypes, we need not make such an assumption.
Example NCP Calculation for 2 Phenotypes Consider our null hypothesis H 0 : μ 01 = μ 11 = μ 21 , μ 02 = μ 12 = μ 22 for 3 genotype groups ( i = 0, 1, 2) with the bivariate phenotypes ( j = 1, 2), that is, p = 2 and g = 3. Thus, s = min( g -1, p ) = 2. These means are determined using the information from the section above (Methods, notation for QTs).
Let with the correlation coefficient ρ . These matrices are specified so that we may test the null hypothesis H 0 : μ 01 = μ 11 = μ 21 , μ 02 = μ 12 = μ 22 stated above. We can calculate the 2 × 2 matrix Φ * as , , ,
The matrix Φ * is used to compute the eigenvalues φ * i , which in turn are used to compute the Pillai statistic and the NCP.
Let us define the terms S ij as 
The power of the Pillai trace test is obtained by
where f α , df 1 , df 2 is the (1 -α ) quantile of a central F distribution with df 1 and df 2 degrees of freedom, respectively, and F ( df 1 , df 2 , λ ) is a noncentral F random variable with NCP λ and degrees of freedom df 1 and df 2 , respectively. For our example, df 1 = r C r A = 4 and
Bivariate Example
For the remainder of this work (excluding the Discussion), we focus on bivariate distribution, that is, on pleiotropic diseases with 2 QTs. We do this because results are more easily interpreted, and because we can present graphs of functions such as the cumulative distribution function .
MSSN Calculations Using a Factorial Design
We asked the following question: which factors most substantially alter the calculated MSSN when testing for genetic associations with a pleiotropic gene affecting 2 phenotypes?
To answer this question, we used a 2 4 × 3 3 factorial design [see 108 ] on a total of 7 design variables (factors) to approximate the calculated MSSN with functions of the design variables. These factors are listed in Table 1 . Note that we obtained 2 4 × 3 3 = 432 vectors of factor settings and therefore 432 MSSN calculations. One benefit of the factorial design is that we can look at multiple factors jointly over a broad range of settings and assess the factors that change the outcome variable the most. For all MSSN calculations, we specified that the fixed power is 0.80 and the significance level is 5 × 10 -8 .
Approximation of the Calculated MSSN
After we computed all 216 MSSN values for the Pillai test, as well as all 432 MSSN values (we compute the number of affected individuals needed and set the number of unaffected individuals to be equal to the number of affected individuals, i.e., r = 1) for the genotype test and the LTT, we performed a linear model analysis (i.e., ANOVA) on the 7 main factors ( Table 1 ) and all 2-way interactions. The ANOVA calculations were performed using the methods developed for the R statistical software package [106] .
Our rationale for performing the ANOVA with the factorial design was as follows: Equation 1 above and Equations A8.1 and A9.1 in the online supplementary material (for all online suppl. material, see www.karger.com/doi/10.1159/000457135) are closed-form equations that specify the NCPs (from which the MSSN may be calculated). Here, the MSSN is given by n = n ( r , w k , g ik ), where i = affection status, k = genotype. Although they are analytic, it is difficult to identify the variables that are most important. Consequently, we approximated the exact function by a linear model (including all 2-way interactions) n  ( r , w k , g ik ) = μ + μ r + … . We used 432 settings for our linear model approximation (216 for the Pillai statistic, since it is not dependent upon percent-affected and percent-unaffected settings) and report the factors that most fully explain the MSSN.
We note here and in the Results section that we do not attempt to make statistical inferences from our applications of the factorial design and ANOVA. Rather, we use them as explanatory tools specifically documenting the factors (main and interaction) that appear to have the most substantial effect on altering the MSSN (i.e., those with the largest F -statistics), and then documenting quantitatively whether the results appear to be true. We can do this by computing MSSNs considering different settings of the aforementioned factors and checking whether the different settings produce substantially different MSSN estimates.
Results

Factors that Most Significantly Alter the Genetic Association Test MSSN Genotype Test
In Table 2 , we report the results of our ANOVA for the genotype test. Overall, this statistic on average had the smallest MSSN requirements for any set of factor settings in Table 1 . This result is notable, since the genotype test has 2 degrees of freedom (df); thus, one might expect the LTT to have lower MSSN values. Also, the genotype test is applied to categorical data, and it is generally true that for quantitative data, quantitative data-based tests such as Pillai's will require smaller MSSNs than do tests on categorical data. We examine this point further in the Discussion section.
In Table 2 , the factors are sorted from the largest to the smallest F -statistic. Also, we report the value φ 2 , the respective factor's proportion of the overall sum of squares ( SSQ ). Specifically, 2 Factor
Total
SSQ SSQ
(values are provided in Table 2 ). Based on the F -statistics and the φ 2 values, we may infer that there are 5 main factors that most substantially influence the number of affected individuals needed to detect an association. These are, in order of the F -statistic (rounded to nearest integer from Table 2 ): percent-affected ( F -statistic = 33,815); ρ (correlation) ( F -statistic = 18,670); σ 2 1 ( F -statistic = 13,265); σ 2 2 ( F -statistic = 6,688); and p d ( F -statistic = 6,568). Along with their 2-way interaction terms (a total of 10), these 5 factors account for 98% of the proportion of the total SSQ ( SSQ Total ) ( Table 2 ). The dominanceadditivity ratios τ 1 and τ 2 had a relatively small impact on the calculated MSSN. This result suggests that the genotype test is equally powerful when the QT loci (QTLs) operate in either an additive or a nonadditive mode of inheritance. That is, researchers need not focus on whether their traits of interest deviate from an additive mode of inheritance when performing MSSN calculations.
Given these results, we performed a regression analysis in which we used the 5 main-effect terms and their 2-way interaction. The results of the regression analysis are provided in Table 3 . As main be seen in Table 3 and Equation  2 below, there are actually 6 "main"-effect terms, since there are 3 settings for the correlation factor ρ ; hence, we need 2 separate variables. Our goal was to compute the coefficients of the fitted sample size equation:
Here, D is the number of factors (5 in this case), and ψ z is the number of df for the z -th factor, 
where: The values in the column labeled "Factor" are defined in Table  1 . The column SSQ Factor is the sum of squares for the given factor. The column labeled "φ 2 " lists each factor's proportion of the overall sum of squares. That is, φ 2 = SSQ Factor /SSQ Total . All values with exception of those in the last column are computed using methods developed for the R statistical software package [106] . Table 3 ). These results are consistent with the F -statistic values in Table 2 .
Finally, a review of the results in Table 3 suggests that the MSSN is decreased the most when σ 2 1 = 0.10, since every coefficient that contains σ 2 1 = 0.10 (with the exception of coefficients for the third-to-last and second-to-last rows of Table 3 ) is negative. This result is consistent with the fact that increasing QTL variance increases the separation among the component multivariate normal distri- Here, we present the results of a linear regression using the 5 most significant factors from Table 2 . We include all 2-way interactions of these factors. An example description of the factors is as follows: "ρ = 0.33" means: if the setting of correlation is 0.33, use the coefficient 81.701 (second column) when computing the fitted value. Otherwise, use 0. We computed coefficients for the other main factors in the same manner. For the 2-way interactions, consider the example "percent-affected = 25, p d = 0.33." Here, if the disease allele frequency setting is 0.33 and the percent-affected setting is 25, then the coefficient used for the fitted values is -38.954, otherwise it is 0. All values were computed using methods (specifically, the lm and summary commands) developed for the R statistical software package [106] . All values in the last 3 columns are rounded to 3 decimal places. In Figure 1 , we present a plot of the fitted values (using Equation 3) versus the analytic MSSN ( n = n A + n U ) determined using the NCP (online suppl. material, Equations A8.1 and A8.2). The coefficients of the trend line, computed using the method in Excel, are consistent with the finding that the analytic MSSNs are accurately approximated by a linear combination of the 6 variables x 1 , …, x 6 ( Table 3 ) and their 2-way interactions. We base this conclusion on the fact that the trend line intercept is 0.0005 (close to 0) and the slope is exactly 1. From this we may conclude that for the parameter settings considered in Table 1 , only 5 of the 7 factors are needed to approximate the analytic MSSN, and that among them, percentaffected/unaffected and the correlation ρ make the greatest change. Since percent-affected/unaffected is the only variable that researchers can control, in order to decrease MSSN requirements, one should decrease the percentaffected value to a 10% threshold (set x 1 to 0 in Equation 3). Doing so will decrease the fitted MSSN by approximately 139 individuals (coefficient of x 1 in Equation 3 ). In the online supplementary material, we computed analytic MSSNs over a range of percent-affected/unaffected values for the genotype test and the LTT and document that as the percent-affected/unaffected setting approaches 0%, so does the MSSN (online suppl. material, Fig. A4 ).
Computation of Power and Sample Size for Genetic Association Studies
Linear Trend Test
The results of the LTT are very similar to those of the genotype test, although the MSSN requirements are generally higher. We placed the results of our analyses in the online supplementary material (Table A2) . Also, see the Discussion section.
Pillai Test
We provide the results of our ANOVA for the Pillai test in Table 4 . Overall, this statistic had the largest MSSN requirements for any set of factor settings in Table 1 . Note that the factor percent-affected/unaffected is not used when computing MSSN requirements for the Pillai statistic, because we use QTVs on all individuals, not just those whose values are above/below a threshold. Hence, we computed the ANOVA for a total of 432/2 = 216 vectors of settings from Table 2 .
As in Table 2 , the factors considered in our ANOVA are sorted from the largest to the smallest F -statistic, and we report the φ 2 values (listed in Table 4 ). Considering the F -statistics and the φ 2 values, we infer that there are 3 main terms that most substantially affect the MSSN to detect associations. These are, in order of the F -statistic (rounded to nearest integer): σ Table 4 , we performed a regression analysis in which we selected the 3 main-effect terms (a total of 4 variables, given the 2 settings of correlation) and their 2-way interactions. We present the results in Table 5 .
From Table 5 In Figure 2 , we plotted the fitted values (using Equation 4) versus the analytic MSSN ( n = n A + n U ) determined using the Pillai NCP (online suppl. material). As with Figure 1 , the coefficients of the trend line, computed using the method in Excel, are consistent with the finding that the analytic MSSNs are accurately represented by a linear combination of all terms in Equation 4 (the trend line intercept is 0.0004, the slope is 1.0). In contrast to the genotype test results, for the Pillai test, we required only 3 of the 6 factors to approximate the analytic MSSN ( Table 6 ; Fig. 3 ) . Also, the MSSN requirements had decreased most substantially by increasing the QTL variances σ 
Which Method Produces the Smallest MSSN Requirements?
So far, we have answered the questions of which factors most substantially alter MSSN requirements, and by how much, for the genotype test, the Pillai test, and the LTT (online suppl. material) for the factor settings in Table 1 . An equally important question is: which statistic produces the smallest analytic MSSN requirements for any vector of factor settings in Table 1 ? To answer this question, we computed the 5 sets of differences: The legend to this table is virtually identical to the legend to Table 2 , with the exception that the "percent-affected" factor is not considered, since the Pillai statistic is computed on all individuals. All values with the exception of those in the last column were computed using methods developed for the R statistical software package [106] .
Each of the differences in MSSN is computed as a function of the parameter settings. Differences II-V are computed with a fixed value for the last parameter (percent-affected). The reason is that the Pillai test is a function of only 6 parameters in Table 1 ; as noted previously, it is not a function of the percent-affected parameter. For each of the Differences I-V, we present the empirical distributions of the results in the form of box plots. These box plots may be found in Figure 3 .
Note that Difference I is computed over 432 vectors, while Differences II-V are computed over 216 vectors. Some of the key findings resulting from a study of Figure  3 are that the genotype test usually has the smallest sample size (previously mentioned) and that the genotype test and the LTT almost always require smaller analytic MSSNs than does the Pillai test. In fact, viewing the 4 rightmost box plots, the greatest difference between the Pillai and any of the other test statistics, where Pillai requires a In this table, we present the linear regression analysis coefficients for the 3 most significant factors from Table 4 . Also, we include all 2-way interaction terms. Similar to Table 3 , we have the following factor descriptions: "σ 2 1 = 0.10" means: if the setting of the first phenotype's quantitative trait locus variance is 0.10, use the coefficient -277.541 (second column) when computing the fitted value. Otherwise, use 0. We computed coefficients for the other main factors in the same manner. Computation for the interaction factors is described in the legend to Table 3 . All values were computed using methods (specifically, the lm and summary commands) developed for the R statistical software package [106] . In Table 6 , we present the differences in Figure 3 as ratios. Lehmann and Romano [109] , among others, defined these ratios as asymptotic relative efficiencies. We report the minimum, median, mean, and maximum ratios for all pairs of test statistics. In this way, we could compare results across columns. The smallest median and mean values -1.35 and 1.26, respectively -were for the LTT/genotype MSSN ratio. This result suggests that the MSSNs for these 2 test statistics are most similar. The largest median and mean values of 3.41 and 3.37 were for the Pillai/genotype (10%) MSSN ratio. This result is consistent with the fact that the "genotype (10%) -Pillai" MSSN box plot has the lowest range of differences (vertical axis) in Figure 3 .
For all ratios below the median ratio of 1.35 for the LTT/genotype MSSN ratio, every vector has the disease allele frequency setting p d = 0.05. This result suggests that In this table, we use the abbreviations "LTT (x%)" and "genotype (x%)" to signify the MSSNs for the LTT and the genotype test, respectively, when the percent-affected/unaffected settings are x (x = 10 or 25%). Also, each column's pair of tests corresponds to the same numbered column in Figure 3 . For example, the first pair of tests is the LTT and the genotype test. The same pair is considered in the first column of Figure 3 . MSSN, minimum sample size necessary. Box plots for all pairs of statistical test differences in analytic MSSN. ◇ , mean value of differences; upper horizontal end of gray box, 3rd quartile (3 Q ) of values (75% of the differences are less than the value corresponding to this line); black horizontal line inside gray box, median value (50% of the differences are less than the value corresponding to this line and 50% are greater than the value); lower horizontal end of gray box, 1st quartile (1 Q ) of values (75% of the differences are greater than the value corresponding to this line); end of upper whisker, maximum value for the set of differences x that satisfy the condition 1 Q -1.5 δ ≤ x ≤ 1.5 δ + 3 Q , δ = 3 Q -1 Q = interquartile range; end of lower whisker, minimum value for the set of differences x that satisfy the inequality listed directly above; * , value y that satisfies either 1. LTT and genotype test MSSNs are most similar for smaller disease allele frequencies.
Finally, we note that we have developed software to perform these calculations. This software will be made available online within the near future. Researchers who want stand-alone copies of the software may contact the first author.
Discussion
In this work, we presented the method (the genotype test) for computing asymptotic power and MSSN calculations for genetic associations with pleiotropic traits. In our design, affection status is defined through thresholds. We included computations of power and MSSN for MANOVA by applying Pillai's statistic.
The first observation we make is that we could specify a multivariate function to compute probabilities for pleiotropic phenotypes (Formulas A1 and A2 in the online suppl. material). Also, we derived categorical data from the QTVs and applied the genotype test and LTT to the categorical data (Equation A4 in the online suppl. material). Furthermore, we computed analytic power and MSSN formulas for the genotype test and LTT (Formulas A8.1 and A9.1 in the online suppl. material), as well as analytic power and MSSN formulas for the Pillai MANO-VA test applied to all QTVs.
Our ANOVA results for the factorial designs indicate that, for the genotype test, the factors that most substantially alter MSSNs are correlations between the 2 QTs ( ρ ) and the percent-affected/unaffected settings. From the results from Table 3 and Equation 3 , we see that the MSSN decreases with a decrease in the correlation and a change of the percent-affected/unaffected setting from 25 to 10%. Changes in these 2 factors reduce the MSSN for the LTT as well (results not shown). We comment that we used the ANOVA to provide a numerical approximation (with linear and 2-way interaction terms) to the analytic formulas for the MSSN. The factors we considered in the approximation are those with the largest F -statistic values.
For the Pillai test, the analytic MSSN is accurately described by settings in 3 factors and their interactions: σ When comparing all the MSSNs for all tests, we see that the genotype test usually requires the smallest MSSN to achieve 80% power at the 5 × 10 -8 significance level for the vector of settings in Table 1 . We draw this conclusion by studying the box plots of MSSN differences for all pairs of test statistics. The only test statistic that has a smaller MSSN than the genotype test for any significant portion of vector settings is the LTT. In fact, for 110/432 (25%) of the vectors, the LTT has an MSSN that is as small as or smaller than that of the genotype test. However, the maximum difference is 14 individuals, and the relative efficiency is never less than 95% ( Table 6 ) .
While this work focused on sample size calculations, through use of NCPs we can just as easily perform power calculations for a fixed sample size. The conclusions we draw about the 3 statistics are the same (e.g., the genotype test has the largest power on average for the different vectors of factor settings, followed by the LTT, etc.) (data not shown).
What if a SNP we are studying is in linkage disequilibrium with a disease gene but not the gene itself [23] ? In such circumstances, we use the method implemented by others [e.g., 87 , 88 ] to perform power and MSSN calculations of threshold-selected QTLs that are in linkage disequilibrium with a disease locus.
A final and very important issue to address is the fact that the Pillai test, which is applied to quantitative data for all individuals, has larger MSSN values than either the genotype test or the LTT. Our explanation for this result is that our design focuses on MSSN calculations before any data are collected. Also, our focus is on gene mapping, not on tests of linearity. If one were conducting a population-based study, where phenotype and genotype values were collected on all individuals, and all 3 test statistics were applied to all individuals, then the Pillai statistic would typically have the smallest sample size requirement.
Consider the following example of vector settings: p d = 0.05, σ 2 1 = 0.10, τ 1 = 0.0, σ 2 2 = 0.05, τ 2 = 0.50, ρ = 0.0, percent-affected-phenotype 01 = (top) 100%, percentaffected-phenotype 02 = (top) 50%, percent-unaffectedphenotype 01 = (lower) 100%, percent-unaffected-phenotype 02 = (lower) 50%. The parameter settings (with the exception of percent-affected and percent-unaffected) are taken from Table 1 .
Regarding the affection thresholds, imagine a square. If we draw a horizontal line through the square, cutting it in half, affected individuals are those subjects whose pair of QTVs are in the upper half of the square, and unaffected individuals are those subjects whose pair of QTVs are in the lower half. With these thresholds, we use all the individuals for the genotype test and LTT, as well as the Pillai test. Applying our formulas, we compute that MSSNs are 1,471 for the genotype test, 1,387 for the LTT, and 326 for the Pillai test for a 5 × 10 -8 significance level. The Pillai MSSN is much lower than that for either of the categorical data-based tests.
Similarly, if we define affection by using a vertical line rather than a horizontal line, our MSSNs are 836 for the genotype test, 785 for the LTT, and 326 for the Pillai test (the Pillai statistic is not dependent upon threshold settings). That is, the Pillai MSSN is less than half of that of either of the categorical data-based tests.
Another practical issue regarding lower values for percent-affected (like 10%) is that for small or moderate MSSNs, one may not observe individuals with phenotypes in this region. For small and moderate MSSNs, the thresholds may be theoretically desirable but impractical. In such circumstances, one might have no choice but to increase the percent-affected threshold.
Finally, we comment that the software to perform power and sample size calculations for pleiotropy is freely available for Windows and Ubuntu Linux. We anticipate to have a Web-based and/or R version of the software ready soon.
